Delgocitinib
CAS 1263774-59-9Small Molecule
Overview
Delgocitinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297507).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Delgocitinib expires 19 Sept 2031 and exclusivity 23 Jul 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile
- Canonical SMILES
- C[C@H]1CN([C@]12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N
- InChIKey
- LOWWYYZBZNSPDT-ZBEGNZNMSA-N
Verified Supplier Partner
Do you supply Delgocitinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.